DarioHealth Corp. (NASDAQ: DRIO) stock plunged by 1.05% at last close while the DRIO stock price declines by 5.39% in the pre-market trading session. DarioHealth Corp. is a worldwide digital therapeutics leader that is changing the way patients with chronic illnesses manage their health.
DRIO stock’ Recent Development
DarioHealth has introduced Dario Move, a new digital-physical therapy solution for managing common musculoskeletal (MSK) disorders that cost businesses and health insurers a lot of money. The solution was introduced at HLTH 2021, one of the biggest conferences for health innovation, which was held in Boston from October 17 to 20, in a hybrid format (in-person and virtual).
Dario’s whole suite is now set to provide complete chronic disease care across three of the top objectives for employers: diabetes, behavioral health, and metabolic health requirements, due to the launch of Dario Move.
According to a recent study of large employers, the cost of musculoskeletal health care has climbed dramatically over the previous decade, ranking it one of the most expensive ailments for employers today. Despite the fact that MSK disorders affect half of all adults in the United States, many people who may benefit from typical low-cost therapies like physical therapy never seek help. By moving the location of treatment to each person’s home, Dario Move’s digital-physical therapy gives a better solution to increase access. Digital physical therapy allows for more cost-effective, measurable, and long-term participation.
Erez Raphael, CEO, and President, DarioHealth commented,
Dario Move’s introduction is an important milestone for the company. The Upright MSK solution has been effectively and quickly incorporated into their complete multi-chronic disease digital therapeutics platform. They will continue to increase their market-leading breadth and reach. Dario Move is the culmination of their idea for multi-use applications of the sensor technology they acquired when they bought Upright, and it opens up a huge new market. Furthermore, they think that integrating their multi-chronic platform increases the platform’s buyer appeal as well as its capacity to provide outcomes and value to its partners.
